US Stock MarketDetailed Quotes

WORK Medical Technology (WOK)

Watchlist
  • 1.210
  • +0.040+3.42%
Close Apr 17 16:00 ET
  • 1.200
  • -0.010-0.83%
Post 19:56 ET
2.09MMarket Cap-1.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

WORK Medical Technology (WOK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
Total revenue
-14.41%9.85M
-15.18%11.51M
-31.18%13.57M
-57.02%19.71M
-12.68%45.86M
52.53M
Operating revenue
-13.85%9.83M
-14.94%11.41M
-31.12%13.41M
-57.54%19.47M
-13.11%45.86M
--52.79M
Excise taxes
----
----
----
----
----
--259.67K
Cost of revenue
-13.13%7.5M
-8.33%8.64M
-38.38%9.42M
-58.92%15.29M
-10.69%37.22M
41.68M
Gross profit
-18.25%2.34M
-30.77%2.87M
-6.24%4.14M
-48.85%4.42M
-20.35%8.64M
10.85M
Operating expense
-50.66%3.24M
79.60%6.57M
40.97%3.66M
168.70%2.59M
-80.13%965.34K
4.86M
Selling and administrative expenses
-33.36%4.41M
92.79%6.61M
-4.66%3.43M
-19.81%3.6M
7.64%4.49M
--4.17M
-Selling and marketing expense
1.23%2.08M
30.98%2.05M
51.78%1.57M
-35.19%1.03M
19.76%1.59M
--1.33M
-General and administrative expense
-48.94%2.33M
144.83%4.56M
-27.39%1.86M
-11.34%2.56M
1.95%2.89M
--2.84M
Research and development costs
43.90%435.31K
0.29%302.51K
64.03%301.64K
-1.37%183.9K
-76.62%186.45K
--797.38K
Other operating expenses
-361.82%-1.6M
-366.88%-346.57K
93.74%-74.23K
67.98%-1.19M
-3,382.54%-3.71M
---106.43K
Operating profit
75.79%-895.53K
-860.31%-3.7M
-73.34%486.46K
-76.22%1.82M
28.14%7.67M
5.99M
Net non-operating interest income expense
41.04%-321.84K
-48.60%-545.84K
-4.65%-367.32K
-6.52%-351K
-26.73%-329.52K
-260.03K
Non-operating interest income
1,449.26%181.68K
-53.86%11.73K
1,190.86%25.42K
--1.97K
----
----
Non-operating interest expense
-9.69%503.52K
41.97%557.57K
11.27%392.74K
7.12%352.97K
26.73%329.52K
--260.03K
Other net income (expense)
-76.61%135.4K
6,717.40%578.76K
97.57%-8.75K
-360.41K
-4.4M
Special income (charges)
----
----
----
----
----
---4.48M
-Less:Impairment of capital assets
----
----
----
----
----
--4.48M
Other non- operating income (expenses)
-76.61%135.4K
6,717.40%578.76K
97.57%-8.75K
---360.41K
----
--82.87K
Income before tax
70.48%-1.08M
-3,420.71%-3.67M
-90.09%110.39K
-84.84%1.11M
452.78%7.34M
1.33M
Income tax
195.02%119.05K
-366.54%-125.29K
-72.26%47.01K
-84.29%169.44K
890.41%1.08M
108.92K
Net income
66.08%-1.2M
-5,685.74%-3.54M
-93.29%63.38K
-84.93%944.13K
413.70%6.27M
1.22M
Net income continuous Operations
66.08%-1.2M
-5,685.74%-3.54M
-93.29%63.38K
-84.93%944.13K
413.70%6.27M
--1.22M
Minority interest income
-166.90%-128.36K
1.14%-48.09K
-161.64%-48.65K
-74.33%78.92K
451.15%307.42K
55.78K
Net income attributable to the parent company
69.28%-1.07M
-3,217.31%-3.49M
-87.05%112.03K
-85.48%865.21K
411.91%5.96M
1.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.28%-1.07M
-3,217.31%-3.49M
-87.05%112.03K
-85.48%865.21K
411.91%5.96M
1.16M
Basic earnings per share
85.19%-400
-3,594.60%-2.7K
-87.05%77.2621
-85.48%596.6966
411.91%4.11K
802.6993
Diluted earnings per share
85.19%-400
-3,594.60%-2.7K
-86.16%77.2621
-86.42%558.2
411.91%4.11K
802.6993
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2025(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020
Total revenue -14.41%9.85M-15.18%11.51M-31.18%13.57M-57.02%19.71M-12.68%45.86M52.53M
Operating revenue -13.85%9.83M-14.94%11.41M-31.12%13.41M-57.54%19.47M-13.11%45.86M--52.79M
Excise taxes ----------------------259.67K
Cost of revenue -13.13%7.5M-8.33%8.64M-38.38%9.42M-58.92%15.29M-10.69%37.22M41.68M
Gross profit -18.25%2.34M-30.77%2.87M-6.24%4.14M-48.85%4.42M-20.35%8.64M10.85M
Operating expense -50.66%3.24M79.60%6.57M40.97%3.66M168.70%2.59M-80.13%965.34K4.86M
Selling and administrative expenses -33.36%4.41M92.79%6.61M-4.66%3.43M-19.81%3.6M7.64%4.49M--4.17M
-Selling and marketing expense 1.23%2.08M30.98%2.05M51.78%1.57M-35.19%1.03M19.76%1.59M--1.33M
-General and administrative expense -48.94%2.33M144.83%4.56M-27.39%1.86M-11.34%2.56M1.95%2.89M--2.84M
Research and development costs 43.90%435.31K0.29%302.51K64.03%301.64K-1.37%183.9K-76.62%186.45K--797.38K
Other operating expenses -361.82%-1.6M-366.88%-346.57K93.74%-74.23K67.98%-1.19M-3,382.54%-3.71M---106.43K
Operating profit 75.79%-895.53K-860.31%-3.7M-73.34%486.46K-76.22%1.82M28.14%7.67M5.99M
Net non-operating interest income expense 41.04%-321.84K-48.60%-545.84K-4.65%-367.32K-6.52%-351K-26.73%-329.52K-260.03K
Non-operating interest income 1,449.26%181.68K-53.86%11.73K1,190.86%25.42K--1.97K--------
Non-operating interest expense -9.69%503.52K41.97%557.57K11.27%392.74K7.12%352.97K26.73%329.52K--260.03K
Other net income (expense) -76.61%135.4K6,717.40%578.76K97.57%-8.75K-360.41K-4.4M
Special income (charges) -----------------------4.48M
-Less:Impairment of capital assets ----------------------4.48M
Other non- operating income (expenses) -76.61%135.4K6,717.40%578.76K97.57%-8.75K---360.41K------82.87K
Income before tax 70.48%-1.08M-3,420.71%-3.67M-90.09%110.39K-84.84%1.11M452.78%7.34M1.33M
Income tax 195.02%119.05K-366.54%-125.29K-72.26%47.01K-84.29%169.44K890.41%1.08M108.92K
Net income 66.08%-1.2M-5,685.74%-3.54M-93.29%63.38K-84.93%944.13K413.70%6.27M1.22M
Net income continuous Operations 66.08%-1.2M-5,685.74%-3.54M-93.29%63.38K-84.93%944.13K413.70%6.27M--1.22M
Minority interest income -166.90%-128.36K1.14%-48.09K-161.64%-48.65K-74.33%78.92K451.15%307.42K55.78K
Net income attributable to the parent company 69.28%-1.07M-3,217.31%-3.49M-87.05%112.03K-85.48%865.21K411.91%5.96M1.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.28%-1.07M-3,217.31%-3.49M-87.05%112.03K-85.48%865.21K411.91%5.96M1.16M
Basic earnings per share 85.19%-400-3,594.60%-2.7K-87.05%77.2621-85.48%596.6966411.91%4.11K802.6993
Diluted earnings per share 85.19%-400-3,594.60%-2.7K-86.16%77.2621-86.42%558.2411.91%4.11K802.6993
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -